Insider Selling: Addus HomeCare (NASDAQ:ADUS) Insider Sells 288 Shares of Stock

Addus HomeCare Corporation (NASDAQ:ADUS) insider Heather Brianne Dixon sold 288 shares of the business’s stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the completion of the transaction, the insider owned 44,371 shares of the company’s stock, valued at $4,160,668.67. This represents a 0.64% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Addus HomeCare Stock Performance

Shares of Addus HomeCare stock traded up $1.03 during trading on Tuesday, hitting $96.06. 221,869 shares of the company’s stock traded hands, compared to its average volume of 241,073. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.83 and a quick ratio of 1.83. Addus HomeCare Corporation has a 1 year low of $87.95 and a 1 year high of $124.43. The stock has a market capitalization of $1.79 billion, a P/E ratio of 17.76, a PEG ratio of 1.29 and a beta of 0.89. The business has a 50-day simple moving average of $93.97 and a 200-day simple moving average of $102.12.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, May 4th. The company reported $1.62 earnings per share for the quarter, topping analysts’ consensus estimates of $1.52 by $0.10. The business had revenue of $363.50 million during the quarter, compared to analyst estimates of $366.41 million. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.Addus HomeCare’s revenue was up 7.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.42 EPS. As a group, analysts forecast that Addus HomeCare Corporation will post 6.24 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Global Retirement Partners LLC boosted its stake in shares of Addus HomeCare by 395.7% during the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after acquiring an additional 186 shares during the last quarter. Larson Financial Group LLC increased its stake in shares of Addus HomeCare by 133.3% in the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after purchasing an additional 136 shares in the last quarter. Acumen Wealth Advisors LLC bought a new position in Addus HomeCare in the 4th quarter worth $29,000. Private Trust Co. NA lifted its position in Addus HomeCare by 65.5% during the fourth quarter. Private Trust Co. NA now owns 283 shares of the company’s stock valued at $30,000 after purchasing an additional 112 shares in the last quarter. Finally, Arax Advisory Partners lifted its position in Addus HomeCare by 95.8% during the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock valued at $30,000 after purchasing an additional 137 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on ADUS. Royal Bank Of Canada restated an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a report on Wednesday, February 25th. Stephens lowered their price target on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a report on Wednesday, February 25th. Wall Street Zen downgraded Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 21st. Weiss Ratings cut Addus HomeCare from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, May 22nd. Finally, Barclays lowered their target price on Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating on the stock in a report on Friday, May 15th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Addus HomeCare presently has a consensus rating of “Moderate Buy” and a consensus target price of $131.00.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.